|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 403.04 USD | -1.04% |
|
-2.79% | +23.14% |
| 10-02 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
ETFs positioned on Amgen Inc.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +17.56% | -.--% | 35,761 M€ | |
| +11.86% | -.--% | 27,154 M€ | |
| +7.42% | -.--% | 49 M€ | |
| +10.32% | -.--% | 66 M€ | |
| +12.07% | -.--% | 67 M€ | |
| +11.10% | -.--% | 67 M€ | |
| +6.49% | -.--% | 75 M€ | |
| +12.96% | -.--% | 122 M€ | |
| +4.20% | -.--% | 165 M€ | |
| -1.10% | -.--% | 33 M€ | |
| +18.38% | -.--% | 669 M€ | |
| +11.20% | -.--% | 1,251 M€ | |
| +26.88% | -.--% | 1,646 M€ | |
| +13.21% | -.--% | 1,674 M€ | |
| +20.25% | -.--% | 2,210 M€ | |
| +16.40% | -.--% | 2,303 M€ | |
| +10.86% | -.--% | 12,921 M€ | |
| +25.46% | 17.04% | 429 M€ | |
| +22.18% | 8.97% | 1,079 M€ | |
| +21.79% | 8.97% | 78 M€ | |
| +21.64% | 8.81% | 9,953 M€ | |
| +21.04% | 7.76% | 81 M€ | |
| +9.50% | 7.16% | 503 M€ | |
| -2.62% | 6.85% | 5 M€ | |
| +15.73% | 5.86% | 379 M€ | |
| +4.47% | 5.41% | 7 M€ | |
| -.--% | 4.96% | 5 M€ |
Employees
31,500
Sector
Pharmaceuticals
- Stock Market
- Stocks
- AMGN Stock
- ETFs Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
